CYP2C19*22/*32 AND Voriconazole response
- Germline classification:
- drug response (1 submission)
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000784655.10
Allele description [Variation Report for CYP2C19*22/*32]
NM_000769.4(CYP2C19):c.296A>G (p.His99Arg)
NM_000769.4(CYP2C19):c.557G>C (p.Arg186Pro)
Condition(s)
- Name:
- Voriconazole response
- Synonyms:
- Vfend response
- Identifiers:
- MedGen: CN077957
Assertion and evidence details
Last Updated: Apr 20, 2024